An observational study in Cognitive Developmental Delay and Birth Weight, sponsored by University of Leeds. Completed. Open to female participants aged 18 Years to 40 Years. Per ClinicalTrials.gov, last updated 2021-10-14.
Sponsored by University of Leeds · Observational
Iodine is a key micronutrient in the diet, essential for healthy growth, and is particularly important during pregnancy and breastfeeding when demands are increased to support the developing baby. Many people are thought to lack all the iodine they need, and this is a greater issue during and shortly after pregnancy when the body's iodine requirements are greatest. Iodine deficiency complications are potentially serious for both mother and child. Iodine deficiency can lead to thyroid enlargement, lower production of important hormones produced by the thyroid, pregnancy complications in the mother, and impaired growth and developmental problems in babies and children. This research will focus on providing an up-to-date estimate of how many pregnant women do not have enough iodine, and what different levels of iodine might mean in terms of health risks during pregnancy and for childhood development. The investigators will investigate how iodine levels vary over the course of pregnancy and lactation, how this is affected by diet, associated changes in thyroid size and function, and what levels of iodine are linked with greater risk of subsequent health problems. The research will take advantage of existing urine samples collected from mothers during pregnancy in the Born in Bradford birth cohort study, where the investigators also know of any adverse pregnancy outcomes, as well as any developmental problems for the baby and in early childhood.
Background: Pregnant women may be particularly vulnerable to iodine deficiency as requirements increase to support fetal development. There is limited information concerning how maternal iodine status changes during pregnancy. Severe iodine deficiency is associated with deleterious health outcomes during pregnancy including gestational diabetes, preeclampsia, stillbirth, and increased mortality. For the fetus, severe iodine deficiency results in reduced birthweight, increased mortality and neurodevelopmental issues. Several studies suggest 40% of pregnant mothers in the United Kingdom (UK) may not meet the World Health Organization (WHO) definition of iodine sufficiency. Although the effects of severe iodine deficiency are known, the impact of mild-to-moderate deficiencies on maternal health and associated fetal and childhood development are not well understood.
Aims:
Research plan and methods: The investigators will utilize the Born in Bradford (BiB) birth cohort which recruited over 12000 pregnant women between 2007- 2009, and has deposited in a biobank 6971 spot urine samples collected at 26-28 weeks gestation.
Data are available on health outcomes during pregnancy including gestational diabetes, preeclampsia, blood pressure, length of gestation, mortality, mental health. Child outcome measures at birth include weight, length, head circumference, small-for-gestational-age. Childhood developmental measures include height, weight, growth trajectories, motor skills, literacy, numeracy and mental health (Strengths and Difficulties Questionnaire, SDQ). Linkage with educational outcomes has been achieved, including Early Years Foundation Stage (EYFS) outcomes and Standard Assessment Tests (SATS) at both Key Stage 1 (KS1) and Key Stage 2 (KS2).
The investigators will measure all maternal urine samples in BiB to allow sufficient power to detect potential modest-sized associations. This will be conducted using Inductively Coupled Plasma Mass Spectrometry (ICPMS). All maternal baseline characteristics and associated outcome data are available for extraction from the primary BiB database.
The investigators will apply multiple logistic regression and multiple linear regression to ascertain potential associations between maternal iodine status and health and developmental outcomes. Cubic splines will be used to model any nonlinear dose-response associations, making no assumptions regarding any predefined thresholds.
The investigators will also conduct a longitudinal substudy to ascertain how iodine status varies between trimesters (The Hiba study). 200 pregnant women will be recruited at 12 week dating scans and the following collected: baseline characteristics, urine samples for iodide analysis, blood for thyroid stimulating hormone (TSH), free thyroxine (fT4) and triiodothyronine (fT3), thyroglobulin, Glomerular Filtration Rate (GFR) based on serum creatinine, visual inspection of the thyroid using standard methods, dietary intake using a validated online 24h recall tool (myfood24). Data collection will be repeated at 26 and 36 weeks' gestation, and 6, 18 and 30 weeks postpartum. The proposed substudy will clarify how iodine status alters in pregnancy and lactation, and any associated thyroid hormone changes. The investigators will identify key sources of iodine in the diet and ascertain dietary patterns associated with different iodine status. To compare results to a more nationally representative sample, spot urines will be analysed from approximately 650 women in the SCOPE birth-cohort (London, Leeds and Manchester).
445 studies on the registry are indexed under Birth Weight; 36 are open to participants now.
This study's enrollment of 246 is above the median of 212 across 136 observational studies indexed under Birth Weight.
Browse Birth Weight studies →University of Leeds is the lead sponsor of 200 studies on the registry; 25 are open to participants now.
Counted across the registry records on this site, refreshed daily.
The Born in Bradford cohort profile is published here: [doi:10.1093/ije/dys112] All women booked for delivery at the Bradford Royal Infirmary at 26-28 weeks gestation. All of the recruited women who provided urine samples are included in our Born in Bradford analysis.
The Hiba longitudinal study replicates this process, but at the 12 week dating scan.
Exclusion criteria:
Urinary iodine concentration during pregnancy at 26 weeks' gestation (Bord in Bradford study) and at 12, 26 and 36 weeks' gestation, 6, 18 and 30 weeks postpartum (Hiba longitudinal study). This is primarily in the form of Iodine to Creatinine ratio, to take spot urine volume into account. There is no intervention in this observational study.
Born in Bradford: Early Years Foundation Stage (EYFS) profiles
The EYFS average points total over 17 domains (score range 17 to 41) and summarised using achievement of Good Level of Development (GLD) (binary).
Time frame: Ages 3 to 5
Born in Bradford: Key Stage 1 (KS1) educational outcomes
Year 1 phonics screening test (score range 0 to 40) and KS1 SATS scores in Reading, Writing, Mathematics and Science (working securely at level 2b or beyond pre-2016 or working at the expected standard or beyond for 2016 onwards, binary) will be presented.
Time frame: Ages 5 to 8
Born in Bradford: Letter identification
Letter identification (standardised)
Time frame: Ages 3 to 5
Born in Bradford: Receptive vocabulary
Receptive vocabulary using the British Picture Vocabulary Scale (BPVS)(standardised)
Time frame: Ages 3 to 5
Born in Bradford: Social functioning
Social functioning using the Strengths and Difficulties Questionnaire (SDQ) total difficulty score and split by domains (e.g. internalising and externalising)
Time frame: Ages 3 to 5
Born in Bradford: Fine motor skills
Fine motor skills using the Clinical Kinematic Assessment Tool (CKAT) overall battery score, along with Tracking, Aiming and Tracing CKAT sub-scores.
Time frame: Ages 3 to 5
Born in Bradford: Birth weight centile
The main birth outcome of interest is birth weight centile, calculated using the version 8.0.1 of the Bulk centile calculator provided by the Gestation Network based at the Perinatal Institute for Maternal and Child Health
Time frame: At birth
Born in Bradford: Apgar score
Apgar score (ordinal).
Time frame: At 1 minute and 5 minutes after birth.
Born in Bradford: Diagnosis of autism
Confirmed diagnosis of autism based on Read codes in linked General Practitioner records.
Time frame: Up to age 11.
Born in Bradford: Diagnosis of attention deficit hyperactivity disorder (ADHD)
Confirmed diagnosis of attention deficit hyperactivity disorder (ADHD) based on Read codes in linked General Practitioner records.
Time frame: Up to age 11.
Hiba longitudinal study: Urinary iodine status
The main outcome of interest is urinary iodine status (primarily in the form of iodine to creatinine ratio to take account of spot urine volumes) changes during pregnancy and lactation (continuous)
Time frame: 12, 26 and 36 weeks' gestation during pregnancy, and 6, 18 and 30 weeks' postpartum.
Hiba longitudinal cohort: thyroid stimulating hormone (TSH)
Changes in thyroid stimulating hormone (TSH) during gestation and lactation.
Time frame: 12, 26 and 36 weeks' gestation during pregnancy, and 6, 18 and 30 weeks' postpartum.
Hiba longitudinal cohort: triiodothyronine (fT3)
Changes in triiodothyronine (fT3) during gestation and lactation.
Time frame: 12, 26 and 36 weeks' gestation during pregnancy, and 6, 18 and 30 weeks' postpartum.
Hiba longitudinal cohort: free thyroxine (fT4)
Changes in free thyroxine (fT4) during gestation and lactation.
Time frame: 12, 26 and 36 weeks' gestation during pregnancy, and 6, 18 and 30 weeks' postpartum.
Hiba longitudinal cohort: thyroglobulin
Changes in thyroglobulin during gestation and lactation.
Time frame: 12, 26 and 36 weeks' gestation during pregnancy, and 6, 18 and 30 weeks' postpartum.
Hiba longitudinal cohort: thyroid size
Changes in thyroid size, measured by palpation, using a standard protocol, during gestation and lactation.
Time frame: 12, 26 and 36 weeks' gestation during pregnancy, and 6, 18 and 30 weeks' postpartum.
Hiba longitudinal cohort: maternal dietary iodine intake (micrograms)
Identification of highest ranking food items in terms of contribution to iodine in the maternal diet as measured using the myfood24 tool
Time frame: 12, 26 and 36 weeks' gestation during pregnancy, and 6, 18 and 30 weeks' postpartum.
Born in Bradford: length of gestation
length of gestation (weeks), presenting pre-term delivery (\<37 weeks)
Time frame: At birth
Born in Bradford: congenital anomalies
Diagnosis of congenital anomalies from linked congenital anomalies records (binary)
Time frame: At birth
Born in Bradford: childhood growth trajectories
Childhood growth trajectories (weight in kg)
Time frame: From 26 weeks gestation, through to age 11
Born in Bradford: Key Stage 2 (KS2) educational outcomes
Key Stage 2 (KS2) SATS scores in English grammar, punctuation and spelling, English reading, and Mathematics.
Time frame: Ages 8 to 11
Born in Bradford: maternal mental health
Patient Health Questionnaire 9 (PHQ-9) depression test questionnaire
Time frame: From 26 weeks gestation, through to age 11
No study locations are listed for this record.
Documents are hosted by the registry — open the source record to download them.
Plan to share: Yes — Born in Bradford welcomes collaboration with other researchers. The BiB website has details of how to submit expressions of interest and has short proformas for these. All suggestions will be reviewed by the BiB Executive Group on a monthly basis, and we aim to get back to potential collaborators within 8 weeks.
This study is completed, as verified in Oct 2021. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
University of Leeds